Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lamivudine (or Emtricitabine).

Autor: Boyce, Ceejay L, Sils, Tatiana, Milne, Ross S, Wallner, Jackson J, Hardy, Samantha R, Ko, Daisy, Wong-On-Wing, Annie, Mackey, Malia, Higa, Nikki, Beck, Ingrid A, Styrchak, Sheila M, DeMarrais, Patricia, Tierney, Camlin, Fowler, Mary G, Frenkel, Lisa M, Team, Promoting Maternal and Infant Survival Everywhere (PROMISE) Study

Publikováno v: Open Forum Infectious Diseases; Jul2024, Vol. 11 Issue 7, p1-10, 10p

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

Autor: Beck, Ingrid A., Levine, Molly, McGrath, Christine J., Bii, Steve, Milne, Ross S., Kingoo, James M., So, Isaac, Andersen, Nina, Dross, Sandra, Coombs, Robert W., Kiarie, James, Chohan, Bhavna, Sakr, Samah R., Chung, Michael H., Frenkel, Lisa M.

Publikováno v: In eClinicalMedicine January 2020 18

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014

Autor: Silverman, Rachel A., Beck, Ingrid A., Kiptinness, Catherine, Levine, Molly, Milne, Ross S., McGrath, Christine J., Bii, Steve, Richardson, Barbra A., John-Stewart, Grace C., Chohan, Bhavna, Sakr, Samah R., Kiarie, James N., Frenkel, Lisa M., Chung, Michael H.

Background: Pre-antiretroviral-treatment drug resistance (PDR) is a predictor of human immunodeficiency virus (HIV) treatment failure. We determined PDR prevalence and correlates in a Kenyan cohort. Methods: We conducted a cross-sectional analysis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2485::82c6909917f4bb977415b3a0b370d6ba
https://hdl.handle.net/10919/107610

Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.

Autor: Milne RS; Seattle Children's Research Institute., Silverman RA; Department of Epidemiology.; Department of Global Health., Beck IA; Seattle Children's Research Institute., Mckernan-Mullin J; Seattle Children's Research Institute., Deng W; Department of Microbiology., Sibley TR; Department of Microbiology., Dross S; Department of Laboratory Medicine., Kiarie JN; Department of Obstetrics and Gynaecology, University of Nairobi., Sakr SR; Coptic Hospital, Nairobi, Kenya., Coombs RW; Department of Laboratory Medicine.; Department of Medicine., Chung MH; Department of Epidemiology.; Department of Global Health.; Department of Medicine., Frenkel LM; Seattle Children's Research Institute.; Department of Global Health.; Department of Laboratory Medicine.; Department of Medicine.; Department of Pediatrics, University of Washington, Seattle, USA.

Publikováno v: AIDS (London, England) [AIDS] 2019 May 01; Vol. 33 (6), pp. 941-951.